Navigation Links
Amicus Therapeutics Announces First Quarter 2008 Financial Results
Date:5/13/2008

.

Other Chaperone Programs:

Amicus is accelerating its investment in research and development to assess the potential for using pharmacological chaperones to treat a broader range of human genetic diseases beyond lysosomal storage diseases. As part of this effort, Amicus continues to conduct preclinical studies in Parkinson's disease, funded in part by a grant from the Michael J. Fox Foundation. In addition to the work in Parkinson's, Amicus is investing in new research aimed at evaluating disease targets for other neurodegenerative disorders and metabolic disorders.

Shire Collaboration:

In November 2007, Amicus entered into a strategic collaboration with Shire Human Genetic Therapies (HGT), a business unit of Shire plc, to jointly develop Amicus' three lead pharmacological chaperone compounds for lysosomal storage disorders, Amigal, Plicera and AT2220. In this collaboration valued at up to $440 million including an up front payment and success based clinical and sales milestones and excluding royalties and cost sharing, Shire also reimburses worldwide development costs on a 50/50 basis. Under the agreement, Shire received rights to commercialize these products outside of the United States. Amicus retains all rights to commercialize these products in the United States. Amicus will lead development operations through the end of Phase 2 clinical trials. The companies will then share responsibility for Phase 3 clinical trial development leveraging Shire's significant ex-US regulatory and clinical experience as well as its commercial infrastructure.

Additional Financial Results & Notes

On a reported basis, the net loss attributable to common stockholders for the three months ended March 31, 2008, was $7.7 million as compared to $9.7 million for the same period in 2007. On a non-GAAP basis, the net loss for the three months ended March 31, 2008, was $6.4 million as compared to $8.9 million and the same period in 2007.

Amic
'/>"/>

SOURCE Amicus Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech 2007 Conference
2. Amicus Therapeutics Announces Third Quarter 2007 Financial Results
3. Meredith Martin Addy Named Chair of AIPLAs Amicus Committee
4. Amicus Therapeutics to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference
5. Amicus Therapeutics to Host R&D Day
6. Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease
7. Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements
8. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
9. Amicus Therapeutics to Present at the BIO CEO & Investor Conference 2008
10. Amicus Therapeutics Presents Positive Data from Phase 2 Clinical Trial of Plicera(TM) for Gaucher Disease
11. Amicus Therapeutics to Present at the Morgan Stanley Global Healthcare Unplugged Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... 29, 2014 Burnham Securities Inc. ("Burnham"), ... ("TCG"), a leader in healthcare venture development and ... alliance to expand the range of services each ... alliance, Burnham Securities will be supported by a ... and management in healthcare industry to build a ...
(Date:9/29/2014)... ZIONA, Israel , September 29, ... stage company developing novel immunomodulators for severe infections, today ... ( BARDA ) has awarded Atox Bio with a ... for the development of AB103 to treat Necrotizing Soft ... and public health threats that end in sepsis. ...
(Date:9/29/2014)... 2014 Westbridge Agricultural Products announced ... a highly effective new tool for organic growers. ... spectrum contact herbicide for post-emergent, non-selective weed control ... crops. The formulation is an emulsifiable concentrate that ... Institute (OMRI) for use in organic food production. ...
(Date:9/27/2014)... interdisciplinary team of University of Pennsylvania researchers has ... sequencing toward measuring other nanoscopic structures. By passing ... in a membrane, the team was able to ... , Their findings suggest new ways of using ... objects at the smallest scale. , The ...
Breaking Biology Technology:Burnham Securities Inc. and The Channel Group Form Healthcare Alliance 2Burnham Securities Inc. and The Channel Group Form Healthcare Alliance 3Atox Bio Awarded Contract Worth up to $24 Million for the Development of AB103 by the Biomedical Advanced Research and Development Authority (BARDA) 2Westbridge Receives EPA Approval for Its New SUPPRESS™ Herbicide EC 2Penn team studies nanocrystals by passing them through tiny pores 2Penn team studies nanocrystals by passing them through tiny pores 3Penn team studies nanocrystals by passing them through tiny pores 4
... ... Processing Leader Applies For Microfluidics Reaction Technology™ (MRT) Patent in Japan , ... Newton, MA ... along with its exclusive Japanese distributor, POWREX Corporation, it has introduced Microfluidics Reaction ...
... ... ... offer a live, interactive Webinar on the benefits and value of implementing MODA-EM™, on Tuesday, ... will feature Marvin Thompson, Manager, Quality Operations at Talecris, and Bob Toal, Vice President at ...
... ... takes a giant step forward with two industry leading companies creating an integration ... ... 19, 2010 -- The world-class preclinical software developer PDS Pathology Data System (PDS) ...
Cached Biology Technology:Microfluidics and POWREX Launch Revolutionary Continuous Pharmaceutical Manufacturing Technology in Japan 2Microfluidics and POWREX Launch Revolutionary Continuous Pharmaceutical Manufacturing Technology in Japan 3Live Webinar: Paperless QC Micro Implemented by Talecris Biotherapeutics 2Live Webinar: Paperless QC Micro Implemented by Talecris Biotherapeutics 3Mettler Toledo and PDS Pathology Data Systems Integrate Powerful Solutions for Faster and More Accurate Preclinical Studies 2Mettler Toledo and PDS Pathology Data Systems Integrate Powerful Solutions for Faster and More Accurate Preclinical Studies 3
(Date:9/29/2014)... 2014 -- Plants have a symbiotic relationship with ... extract nutrients and defend against invaders an ... and vegetables. Now, scientist have discovered that plants ... thus ensuring that sprouting plants are colonized from ... Notre Dame, presented their findings today at the ...
(Date:9/29/2014)... from 2009, "human activities in this area of the world ... is increasingly grown for use as a cooking oil and ... has become the most widely produced edible oil in the ... that of soybean oil. , The environmental effects of such ... grow the crop, and the preferred method is fire. The ...
(Date:9/29/2014)... home should use ventilation when cooking with a gas ... a new study showed an association between gas kitchen ... , "In homes where a gas stove was used ... higher than in homes where a gas stove was ... in the College of Public Health and Human Sciences ...
Breaking Biology News(10 mins):Plants prepackage beneficial microbes in their seeds 2Childhood asthma linked to lack of ventilation for gas stoves, OSU study shows 2Childhood asthma linked to lack of ventilation for gas stoves, OSU study shows 3
... previously developed to measure a toxin found in tobacco ... in people suffering from spinal cord injuries and multiple ... The toxin, called acrolein, is produced in the body ... biochemical events thought to worsen the injury,s severity. Acrolein ...
... structure called "the microtubule network" is a crucial part ... system within nerve cells, carrying essential proteins and enabling ... and Parkinson,s, this network breaks down, hindering motor abilities ... of Tel Aviv University,s Sackler Faculty of Medicine has ...
... PHILADELPHIA (June 13, 2013)Twenty-two of the nation,s most ... Biomedical Sciences by The Pew Charitable Trusts today. ... researching the basis of perplexing health problems such ... new scholars join a prestigious community of researchers ...
Cached Biology News:Testing method promising for spinal cord injuries, multiple sclerosis 2Testing method promising for spinal cord injuries, multiple sclerosis 3A peptide to protect brain function 2From autism to diabetes to Parkinson's disease 2From autism to diabetes to Parkinson's disease 3